Needham Downgrades Sarepta Therapeutics (SRPT) to Underperform

July 21, 2025 6:30 AM

Needham analyst Gil Blum downgraded Sarepta Therapeutics (NASDAQ: SRPT) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found